Loading clinical trials...
Loading clinical trials...
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Conditions
Interventions
methylprednisolone
Placebo
Locations
66
Australia
Concord Repatriation and General Hospital
Concord, New South Wales, Australia
Nepean Hospital
Kingswood, New South Wales, Australia
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
University of Calgary/Alberta Health Services
Calgary, Alberta, Canada
Start Date
May 5, 2012
Primary Completion Date
July 23, 2021
Completion Date
July 23, 2021
Last Updated
September 23, 2021
NCT00004448
NCT01115426
NCT00006137
Lead Sponsor
The George Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions